Skip to content
Awesome – Lifestyle
Author:
Certara
Certara Reports Second Quarter 2026 Financial Results
August 4, 2026
Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026
July 15, 2026
Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit
July 7, 2026
Certara Announces CFO Transition
June 17, 2026
Certara to Participate in Upcoming Investor Conferences
May 18, 2026
Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat
April 29, 2026
AAR reports third quarter fiscal year 2026 results
March 25, 2026
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
March 5, 2026
Certara to Participate in Upcoming Investor Conferences
March 5, 2026